Delivery Order SPE2DB20D1109-SPE2DB23FP00V
Award Date 4/25/23
Potential Completion Date 5/16/23
Potential Value $6.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,627.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of January 9, 2025. The contract is not set aside for any specific business designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $20,114.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and an ultimate completion date of February 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $10,485.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 18, 2024. The contract is not set aside and was awarded on a full and open competition...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,621.20 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide 4,563,910,634 units of XEOMIN 100 unit vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XEOMIN 200 unit vials. The firm-fixed-price delivery order, valued at $4,193.92, has an ultimate completion date of August 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This firm-fixed-price delivery order, valued at $6,508.32, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 100 unit vials, with a completion date of December 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,539,302 units of XEOMIN 200 unit vials. The $10,485.00 award has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of 4,560,683,339 units of XEOMIN 200 unit vials. The $6,290.88 firm fixed price delivery order has a completion date of May 12, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...